you are viewing a single comment's thread.
Looks like a non issue as far as I can tell. A few retail folks sold after hours for as low as $44.19.
Yeah for a whopping 5,545 shares sold after 6pm announcement.
To qualify my quote from the acquisition article:Of the $154.5 in sales for CV Theraputics in 2008 Ranexa accounted for $112.9.So obviously the main reason for the acquisition. But about 2% of Gilead's sales based on 2008 #'s.Agreed, no conviction selling after hours... Just a few retailers jumping ship on light Friday evening interest.I'd prefer good news though :)UBadger